Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Quick Stats
Jan 30, 202651.4
AI Score
HOLD0.24
Volume Ratio
Mar 17, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
XCUR Stock Summary
Last updated Jan 30, 2026
XCUR is currently trading at $4.07, positioned below its 200-day moving average of $6.58, suggesting bearish momentum. The stock has a 52-week range of $3.1006 to $15.91.
Technical Analysis: The 50-day moving average stands at $5.45, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 30.007, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.209, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates XCUR at 51.4/100 with a HOLD recommendation.
XCUR (Exicure, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 30.007 |
| CMF (20) | -0.209 |
| ROC (10) | -34.88 |
| ADX (14) | 36.118 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.302 |
| AROONOSC (14) | -35.714 |
| WILLAMS %R (14) | -97.353 |
| MFI (14) | 46.417 |
XCUR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
XCUR Price vs Max Options Open Interest
XCUR Max Change In Options Open Interest
XCUR Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XCUR Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XCUR Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XCUR Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Exicure, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
XCUR Moving Averages Analysis
XCUR (Exicure, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 5.33 |
| 20 | 5.6 |
| 30 | 5.67 |
| 50 | 5.45 |
| 100 | 4.85 |
| 200 | 6.58 |
XCUR Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 25.9 million |
| Earnings/Share ($) | -3.72 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 2 |
| Most Recent Quarter |
Exicure announced positive Phase 2 data for burixafor in multiple myeloma, with 89.5% meeting the primary endpoint. $YGMZ is under accumulation pressure. $XCUR is moving. $PFSA is next $XCUR. $XCUR may see more gains if it breaks $9.80. $XCUR is aiming for new all-time lows and potentially penny land.
Updated 2025-12-09 09:00:02